Pharmafile Logo
Pharmafocus logo
Advanced Search

Avandia

Showing 15 posts of 25 posts found.

FDA U-turn on Avandia

November 26, 2013
Sales and Marketing Avandia, CDER, FDA, GSK, diabetes, nissen, type 2

The FDA has delivered a shock verdict that the stringent restrictions on GlaxoSmithKline’s diabetes medicine Avandia should be lifted, despite …

News
GSK image

China accuses GSK of large scale bribery

July 12, 2013
Medical Communications, Research and Development, Sales and Marketing Avandia, China, GSK, Seroxat

Health officials in China say they have found evidence GSK tried to generate sales and raise drug prices by bribing …

News

GSK slams Guardian article

January 31, 2013
Sales and Marketing Avandia, FDA, GSK, Guardian

GlaxoSmithKline has slammed an article about its controversial diabetes treatment Avandia in The Guardian newspaper, saying that some of it …

News

Ethical dilemmas add to ‘critical weaknesses’ In FDA safety monitoring

August 25, 2012
Sales and Marketing Avandia, Post-marketing surveillance, pharmacovigilance

Ethical challenges are central to continuing “critical weaknesses” in the FDA’s drug safety monitoring, according to a commentary by former …

News

GSK to pay ‘unprecedented’ $3 billion fraud charge

July 3, 2012
Business Services, Sales and Marketing Avandia, Bextra, GSK, Paxil, Wellbutrin, Witty

GlaxoSmithKline will pay $3 billion in fraud charges, the largest of its kind in US history. The charges relate to …

News
EMA image

EMA publishes updated diabetes guidelines

July 2, 2012
Research and Development, Sales and Marketing Avandia, EMA, GSK, R&D, Takeda

The European Medicines Agency has published new guidance on what it wants to see from firms submitting new diabetes treatments. …

News

GSK profits slump amid ongoing Avandia woes

February 7, 2011
Sales and Marketing 2010 pharma results, Avandia, GSK, GlaxoSmithKline

GlaxoSmithKline’s ongoing woes with diabetes drug Avandia hit profits in 2010. Profits after tax plummeted 56% to £3 billion for …

News

GSK settles Avandia case out of court

February 1, 2011
Sales and Marketing Avandia, GSK, diabetes

GlaxoSmithKline this week settled a US federal lawsuit regarding its diabetes drug Avandia before it went to court. The company …

News

GSK takes £2.2bn hit from Avandia claims

January 18, 2011
Sales and Marketing Avandia, GSK, GlaxoSmithKline, rosiglitazone

GlaxoSmithKline’s Avandia woes are continuing, with the company admitting it expects to take a mammoth legal charge over the troubled …

News

2010: Pharma’s year in review

December 23, 2010
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 2010, Avandia, China, European healthcare spending, GSK, Obama, year in review

2010 saw a harsh new economic reality dominate decisions in the US and Europe, but pharma seized on opportunities in …

Feature
GlaxoSmitKline's headquarters

Revenue slump for GSK as Avandia sales stall

October 22, 2010
Sales and Marketing Avandia, GSK, GlaxoSmithKline, UK science budget, patent box, pharma's 2010 results, pharma's Q3 results

GlaxoSmithKline has posted a third quarter loss after sales of its troubled diabetes drug Avandia and pandemic influenza products fell. …

News
GSK's Dr Pim Kon

Avandia should still be on the market, says GSK

October 7, 2010
Sales and Marketing Avandia, GlaxoSmithKline

GlaxoSmithKline believes European regulators were wrong to withdraw its diabetes drug Avandia from the market, but will not challenge their …

News

Avandia withdrawn in Europe, but remains in US

September 24, 2010
Sales and Marketing Avandia, FDA, pharmacovigilance, safety

GSK’s diabetes drug Avandia is to be withdrawn from the market in Europe because of high levels of heart attack, …

News

Pressure mounts on GSK over Avandia

September 6, 2010
Sales and Marketing Avandia, GlaxoSmithKline

GlaxoSmithKline is under mounting pressure this week as calls intensify for its type II diabetes drug Avandia to be withdrawn …

News

Avandia letter misleading, FDA tells Glaxo

August 24, 2010
Sales and Marketing Avandia, GSK

GlaxoSmithKline’s travails over controversial diabetes drug Avandia show no sign of abating as members of a key regulatory panel accused …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026